Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Trial, Open Label, Clinical Activity of Metformin in Combination With High-dose of Dexamethasone (HDdexa) in Patients With Relapsed/Refractory Multiple Myeloma

NCT02967276 is registered in ClinicalTrials.gov with University of Campinas, Brazil as lead sponsor.

NCT NCT02967276
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02967276 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Trial, Open Label, Clinical Activity of Metformin in Combination With High-dose of Dexamethasone (HDdexa) in Patients With Relapsed/Refractory Multiple Myeloma
Lead sponsor
University of Campinas, Brazil
Phase
Phase 2
Overall status
Terminated
Start date
January 31, 2017
Completion date
February 29, 2020
Enrollment
28 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

multiple myeloma